<DOC>
	<DOCNO>NCT00272558</DOCNO>
	<brief_summary>The purpose evaluate activity feasibility two drug regimen partly orally partly intravenous advanced pleural mesothelioma .</brief_summary>
	<brief_title>Study Carboplatin Vinorelbine Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>Chemotherapy carboplatin i.v . day one cycle Vinorelbine i.v . day one , orally day 8 cycle , repeat new cycle every 3 week . Total 6 cycle . Endpoint response rate , secondary endpoint survival toxicity .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Histologically verify malignant pleural Mesothelioma Age 18 year Performance status 02 No previous chemotherapy Normal renal , liver bone marrow function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Malignant Pleural Mesothelioma</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>